C-peptide

DRUG4 trials

Sponsors

Creative Peptides Sweden Inc., Janssen-Cilag International NV, University of Cincinnati, Catholic University of the Sacred Heart

Conditions

Diabetes MellitusDiabetes Mellitus, Type 1Diabetic PolyneuropathyHealthyHypoglycemiaMetabolic Syndrome XPancreatic SteatosisType 1 Diabetes

Early Phase 1

Effect of C-peptide on Hypoglycemic Counterregulation

RecruitingNCT06470295

University of CincinnatiHypoglycemia, Type 1 Diabetes

Start: 2024-06-01End: 2028-01-01Target: 38Updated: 2026-02-17

Phase 1

Effects of Canagliflozin on C-peptide Clearance in Healthy Volunteers

CompletedNCT01665638

Janssen-Cilag International NVHealthy

Start: 2012-09-30End: 2012-10-31Updated: 2013-06-07

Phase 2

Effect of C-Peptide on Diabetic Peripheral Neuropathy

CompletedNCT00278980

Creative Peptides Sweden Inc.Diabetes Mellitus, Type 1, Diabetic Polyneuropathy

Start: 2003-10-31End: 2004-12-31Target: 180Updated: 2006-01-19

Unknown Phase

Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells.

RecruitingNCT06801769

Catholic University of the Sacred HeartDiabetes Mellitus, Metabolic Syndrome X, Pancreatic Steatosis

Start: 2025-03-17End: 2026-12-01Target: 100Updated: 2026-03-20